Is there an association between uterine fibroids and Thermal Energy Radiation (TERA) exposure in veterans?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No Established Association Between Uterine Fibroids and TERA Exposure in Veterans

Based on the available evidence, there is no documented association between uterine fibroids and Thermal Energy Radiation (TERA) exposure specifically in veterans. The provided research does not address TERA exposure as a risk factor for uterine fibroids in any population, including veterans.

What the Evidence Actually Shows

Radiation Exposure and Fibroids - Limited Context

The only radiation-related evidence pertains to:

  • Atomic bomb survivors: A 1997 study demonstrated increased uterine myoma prevalence with ionizing radiation exposure from atomic bombs, showing an odds ratio of 1.61 at 1 Gy 1. However, this represents acute, high-dose ionizing radiation exposure—fundamentally different from any occupational or environmental thermal energy exposure.

  • Medical procedure radiation: Multiple studies discuss radiation exposure during uterine fibroid embolization procedures 2, 3, 4, but these address diagnostic/therapeutic radiation doses, not environmental or occupational exposures.

Veterans and Toxic Exposures

Recent data on women veterans with breast and gynecologic cancers shows that nearly 50% report hazardous exposures during military service, with airborne exposures being most common 5. However, this study does not specifically examine uterine fibroids or identify TERA as a documented exposure category.

Established Risk Factors for Uterine Fibroids

The evidence identifies these validated risk factors 6:

  • Age (strongest predictor)
  • Thyroid-stimulating hormone index (TSHI)
  • Number of deliveries
  • Abnormal menstruation
  • Polycystic syndrome

Critical Caveats

The absence of evidence is not evidence of absence. The lack of research on TERA exposure and fibroids in veterans represents a knowledge gap rather than proof of no association. Given that:

  • Uterine fibroids are frequently underdiagnosed, creating measurement bias in epidemiologic studies 7
  • Women veterans report high rates of toxic exposures during service 5
  • The latency period for exposure-related conditions may be prolonged

If you are evaluating a veteran with uterine fibroids and suspected TERA exposure, document the exposure history thoroughly and consider reporting to the VA's environmental exposure registry, as this may contribute to future epidemiologic surveillance.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.